期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
A new thinprep cytologic test of cervical cells and its application 被引量:1
1
作者 Xiaojun ZHAO Jingjuan WEI +2 位作者 Rong WANG Yajun GU Yunde LIU 《Frontiers of Medicine》 SCIE CSCD 2009年第2期227-229,共3页
In order to improve the quality of routine cervical smears,we investigated the new Thinprep cytologic test(TCT)for cervical cells.In this study,100 women who were enrolled were randomly divided into two groups.In one ... In order to improve the quality of routine cervical smears,we investigated the new Thinprep cytologic test(TCT)for cervical cells.In this study,100 women who were enrolled were randomly divided into two groups.In one group,the TCT for cervical cells was applied(TCT group),and in the other group routine cervical smear was used.In addition,the cells in the TCT group were screened by double sifters,and centrifuged using a separation medium so as to eliminate mucus,inflammatory cells and blood cells.According to the cell distribution and the thickness of the smear,the results were assigned to three groups,including satisfactory smears,less satisfactory smears and unsatisfactory smears.The TCT had a higher satisfactory rate(98%)compared to the routine cervical smear(32%)(P<0.01),indicating the TCT was superior to the routine cervical smear.It is concluded that the TCT is more acceptable.Meanwhile,in comparison to the routine cervical smear,the TCT for cervical cells has 5 advantages which can greatly increase the cytological accuracy. 展开更多
关键词 thinprep cytologic test cervical cells Papani-colaou smear
原文传递
Follow-up study on ThinPrep cytology test-positive patients in tropical regions
2
作者 Yun-Chun Chen Chong-Nan Liang +3 位作者 Xiang-Feng Wang Min-Fa Wang Xu-Ning Huang Jian-Dong Hu 《World Journal of Clinical Cases》 SCIE 2022年第34期12543-12550,共8页
BACKGROUND As shown in the statistics from the World Health Organization,it is estimated that approximately 75000 new cases of cervical cancer occur every year in China.In 2008,33000 people died of cervical cancer in ... BACKGROUND As shown in the statistics from the World Health Organization,it is estimated that approximately 75000 new cases of cervical cancer occur every year in China.In 2008,33000 people died of cervical cancer in China.It is proven that most women are at risk of cervical cancer.The progression from human papillomavirus(HPV)infection to cervical cancer can be several years or decades,which offers a unique opportunity to prevent cancer.AIM To observe the changes in ThinPrep cytology tests(TCT)and HPV infection in patients who were detected to be positive via TCT screening of cervical cancer and further explore the biopsy results.METHODS This paper performed a follow-up study on 206 cervical cancer screening-positive patients of 12231 total cases from our previous research.We conducted an observational study on the TCT results based on the interpretation of The Bethesda System.RESULTS Over a 5-year period,10 cases received consistent follow-up.The proportions of cases in which glandular epithelial lesions were detected increased over the follow-up period.The differences between the years were statistically significant(P<0.01).Over the 5 years,the proportion of patients whose squamous epithelial lesions transformed into glandular epithelial lesions increased yearly.Annual positive rates of HPV infection were:year 1,73%(24/33);year 2,43%(6/14);year 3,36%(9/25);year 4,50%(9/18);and year 5,25%(6/24).The positive detection rate after biopsy over a 9-year period was 29%.CONCLUSION The follow-up study for 5 years to 9 years revealed a tendency to change from squamous epithelial lesions to glandular epithelial lesions and an improvement of the disease(which had not been reported previously).The HPV test indicated a high negative conversion ratio of the viral infection.However,the follow-up cases were not found to have persistent infection of high-risk HPV.Therefore,early intervention of cervical cancer screening is necessary.Low re-examination compliance,patient education,and preventive measures should be enhanced. 展开更多
关键词 Cervical cancer thinprep cytology test screening Human papillomavirus Follow-up study SCREENING Tropical regions
下载PDF
人乳头瘤病毒多基因型检测对传统部分基因型宫颈癌筛查策略价值优化的敏感性分析 被引量:1
3
作者 戎春宇 揭俊钦 +6 位作者 王贤吉 周萍 蒋虹丽 杜莉 祖恩晴 李欣 李真 《中国卫生资源》 CSCD 北大核心 2023年第4期330-338,共9页
目的评估薄层液基细胞学检查(thinprep cytologic test,TCT)筛查技术的有效性、部分宫颈癌诊断费用和初始人群中人乳头瘤病毒(human papilloma virus,HPV)低度风险基因型感染者占比对HPV多基因型和HPV部分(16/18)基因型检测初筛策略的... 目的评估薄层液基细胞学检查(thinprep cytologic test,TCT)筛查技术的有效性、部分宫颈癌诊断费用和初始人群中人乳头瘤病毒(human papilloma virus,HPV)低度风险基因型感染者占比对HPV多基因型和HPV部分(16/18)基因型检测初筛策略的成本效果影响,为公共卫生决策部门选择宫颈癌筛查策略提供参考。方法基于构建的Markov队列模型,以预防宫颈癌发病例数为效果指标,模型运行50年,对HPV多基因型和HPV部分(16/18)基因型筛查方案进行敏感性分析,分析TCT筛查技术的有效性、部分宫颈癌诊断费用,以及初始人群中HPV低度风险基因型感染者占比的变化对成本效果的影响。结果在设定的模型及各参数阈值下,敏感性分析发现:HPV低度风险基因型(HPV 51/35/39/68/56/59/66型)感染者(HPV感染状况或进展为CIN1/2/3状况)中TCT分流检测的灵敏度与特异度[以TCT结果为不典型鳞状上皮细胞病变(atypical squamous cells of undetermined significance,ASCUS)以上为判别标准]变化对两种筛查策略差距影响较大;TCT检测费用、阴道镜检测费用及组织病理学检测费用对两种筛查策略差距影响相对较小。上述各指标在设定阈值范围内变化时,HPV多基因型与部分基因型策略相比,效果差异甚微,成本差异有所变化,具有成本优势。此外,随着初始人群中HPV低度风险基因型感染者的比例增大,HPV多基因型策略的优势亦逐渐增强。结论进一步明确HPV不同基因型的致病风险对优化多基因型HPV筛查的后续管理路径具有重要意义,而进一步细分TCT检测的TBS(The Bethesda System)分级报告结果,提升TCT检测精度则是保障多基因型HPV筛查防治策略价值优化的关键。 展开更多
关键词 宫颈癌筛查cervical cancer screening 人乳头瘤病毒human papilloma virus HPV 多基因型检测extended genotyping testing 部分基因型检测partial genotyping testing 价值value 成本效果costeffectiveness 敏感性分析sensitivity analysis 薄层液基细胞学检查thinprep cytologic test TCT 不典型鳞状上皮细胞病变atypical squamous cells of undetermined significance ASCUS
下载PDF
人乳头瘤病毒多基因型检测对传统部分基因型宫颈癌筛查策略的价值优化:基于Markov模型的分析
4
作者 揭俊钦 戎春宇 +6 位作者 王贤吉 蒋虹丽 杜莉 周萍 李欣 祖恩晴 李真 《中国卫生资源》 CSCD 北大核心 2023年第4期323-329,338,共8页
目的比较人乳头瘤病毒(human papilloma virus,HPV)多基因型(extended genotyping)与HPV部分(16/18)基因型检测技术对宫颈癌筛查策略及其后续管理的影响,分析可能带来的价值变化。方法基于Markov队列模型,以预防宫颈癌发病例数为效果指... 目的比较人乳头瘤病毒(human papilloma virus,HPV)多基因型(extended genotyping)与HPV部分(16/18)基因型检测技术对宫颈癌筛查策略及其后续管理的影响,分析可能带来的价值变化。方法基于Markov队列模型,以预防宫颈癌发病例数为效果指标,模拟100万名初始年龄为15岁的健康妇女在10、20、30、40、50年内从健康状态到宫颈癌发病的疾病进程,基于2种检测技术的宫颈癌筛查-诊断-癌前病变诊疗路径构建模型,分析2种筛查技术不同累计年份下的效果指标、阴道镜检查次数、宫颈上皮内瘤样病变(cervical intraepithelial neoplasia,CIN)1/2/3状态的筛查率,并比较成本与成本效果,以此判定对价值的影响。结果模型模拟10、20、30、40、50年,HPV多基因型相对于HPV部分(16/18)基因型在成本上分别减少29.73万、75.55万、98.53万、111.23万、119.39万元,效果始终保持一致,阴道镜检测次数可分别减少1002、2726、3865、4605、5086人次,CIN1-3筛查率上,模型运行第10、20、30、40、50年时,HPV多基因型策略分别减少约4%的CIN1-3的筛查率。结论相比于HPV部分(16/18)基因型,HPV多基因型检测技术在保障预防效果的情况下,能降低筛查假阳性带来的阴道镜“过诊”率,提升阴道镜检查精度,优化卫生资源利用效能,一定程度上避免假阳性带来的心理负担,从而优化传统HPV部分(16/18)基因型的筛查价值。 展开更多
关键词 宫颈癌筛查cervical cancer screening 人乳头瘤病毒human papilloma virus HPV 多基因型检测extended genotyping testing 部分基因型检测partial genotyping testing 价值value 成本效果costeffectiveness 薄层液基细胞学检查thinprep cytologic test TCT 不典型鳞状上皮细胞病变atypical squamous cells of undetermined significance ASCUS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部